Competition & Peer Data API & CSV Delivery

Psyence Biomedical Ltd's Competitiveness

Name: Psyence Biomedical Ltd Competitors and Peer Comparison
Creator: CSIMarket
License: https://csimarket.com/help/terms-of-use

A competitive positioning analysis and financial ratio benchmarking of Psyence Biomedical Ltd (PBM) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q4 2024

Competitors Tracked

Publicly traded peers

Peer Group Market Share

100.00 %

Share of combined sales, Q4 2024

Revenue Growth Y/Y

Q4 2024

Net Margin

-7,420,807.66 %

Q4 2024

Key Findings: Psyence Biomedical Ltd vs Its Competitors

TTM: Trailing 12-month revenue of 0M vs -M combined for tracked competitors (100.0% combined share).
Trending: Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months).
Scale: Psyence Biomedical Ltd ranks #481 of 544 companies by market capitalization in the Major Pharmaceutical Preparations industry, holding 0.0% of industry market cap.
Peer revenue share: Psyence Biomedical Ltd accounted for 100.0% of combined revenue among its tracked peer group.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

PBM Sales vs. its Competitors, Q4 2024

Psyence Biomedical Ltd generated 100.00 % of the combined sales of its peer group.

API endpoints for this dataset

                        https://api.csimarket.com/api/v1/companies/PBM/competitors                    

                        https://api.csimarket.com/api/v1/companies/PBM/relationships                    

                        https://api.csimarket.com/api/v1/companies/PBM/similar                    

Programmatic access for models, analytics, and integration workflows.

Pull these exact ratios programmatically

Get an API key License this feed for redistribution / AI →

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Psyence Biomedical Ltd's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity	Profitable	Expanding	Above Industry Growth	Distressed
Psyence Biomedical ltd	-	-	-	Yes
Similar-Size Competitors (9)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

PBM Stock Performance relative to its Competitors

PBM Competitors (weighted) Percent change over the selected range

Psyence Biomedical Ltd's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.

Similar-Size
(1 of 7)

Entity	TTM Share Price Return (group: median)	vs U.S.A. 500
Psyence Biomedical ltd	-95.60 %	Underperformed
Competitors combined (0)	40.4%	63.2%
High-Confidence Competitors (0)	40.4%	63.2%
Similar-Size Competitors (7)	40.4%	63.2%
Similar Growth & Profitability (0)	40.4%	63.2%

Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Psyence Biomedical Ltd's competitor groups requires a Commercial License.

Unlock Commercial Access

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

PBM Stock Performance relative to Similar-Size Competitors

PBM Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

Psyence Biomedical Ltd's Comment on Competition and Industry Peers

Psyence operates in the psychedelic therapy and biotechnology industries, which are characterized by rapid growth, technological change, and consolidation. The company faces competition from entities in Canada, the United States, Europe, and other regions, including multinational pharmaceutical companies, established biotechnology firms, specialty pharmaceutical and generic drug companies, as well as universities and research institutions. Recent U.S. federal initiatives to accelerate the development of psychedelic therapies may provide greater benefits to competitors. Industry consolidations and acquisitions could impact Psyence by resulting in the loss of strategic partners, customers, revenue, and market share, or by increasing competitive pressures and resource requirements.